OTZ Partners LLC dba Remy Laser, LLC

Remy Laser manufactures and distributes Class IV therapeutic laser systems for pain relief, wound healing, and dermatological applications. The company offers two primary product lines: the Remy™ (dual-wavelength 810nm/980nm) and the Remy™ FX (quad-wavelength 810nm/980nm/1064nm), both operating in continuous wave and repeat pulse modes. Indications include temporary relief of minor muscle and joint pain, arthritis pain, muscle spasms, increased local blood circulation, and muscle relaxation. The 980nm wavelength is indicated for podiatric soft tissue ablation, vaporization, incision, excision, and coagulation of periungual, subungual, and plantar warts. The 980nm is also indicated for temporary increase of clear nail in onychomycosis patients. Remy Laser positions itself on clinical effectiveness via photobiomodulation (PBM) technology—multi-wavelength near-infrared light that increases cellular ATP production, accelerates tissue healing, reduces pain and swelling, enhances circulation, and triggers immune response. The company emphasizes affordability, accessible financing, rapid practice integration, and comprehensive post-sale support including training, education, marketing resources, and responsive customer service. Target market includes podiatry, pain management, and physical therapy practices. Devices are restricted to sale by or on the order of a licensed physician and require proper clinical and technical training. Company provides ongoing educational webinars and practice support programs to help providers maximize clinical and financial outcomes.